Log in to save to my catalogue

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1952654554

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

About this item

Full title

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-10, Vol.12 (10), p.e0186615-e0186615

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease. Histone deacetylase 6 (HDAC6) alters function and fate of various proteins via deacetylation of lysine residues, and is implicated in TGF-β1-induced EMT (epithelial-mesenchymal transition). However, the role of HDAC6 in pulmonary fibrosis is unknown.
HDAC6 expressio...

Alternative Titles

Full title

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1952654554

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1952654554

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0186615

How to access this item